Monitoring and Evaluation of the Levothyroxin Replacement Therapy in Pregnant Women With Hypothyroidism
NCT ID: NCT02094079
Last Updated: 2015-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2014-03-31
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A retrospective study of consecutive pregnant women with hypothyroidism followed at the outpatient clinic at the Endocrinology Unit, Herlev Hospital, Denmark during 2012. Patients selected through electronic medical system. Blood tests for the The hormone levels drawn from the laboratory of Clinical Biochemical Department, Herlev Hospital
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Thyroid Hormone Dose Adjustment in Pregnancy
NCT00230802
Thyroid Therapy for Mild Thyroid Deficiency in Pregnancy
NCT00388297
Efficacy of Low Dose Levothyroxine During Pregnancy
NCT03391154
Thyroid Dysfunction and Obstetric Complications
NCT02815501
The Establish of Specific Reference Ranges for Thyroid Tests in Pregnant Women
NCT02966405
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
L-T4 treated hypothyroid pregnant women
L-T4 treated pregnant women
biomedical outcomes
Evaluation of abnormal blodtests (evaluating thyroid function) from predefined control program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
biomedical outcomes
Evaluation of abnormal blodtests (evaluating thyroid function) from predefined control program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Birte Nygaard
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Birte Nygaard
Birte Nygaard, md, phd
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Birte Nygaard, MD, phd
Role: PRINCIPAL_INVESTIGATOR
Endocrine Unit O, Herlev Hospital, University of Copenahgen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Endocrine Unit O, Herlev Hospital, University of Copenhagen
Herlev, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hubaveshka J, Michaelsson LF, Nygaard B. The dose of levothyroxine in pregnant women with hypothyroidism should be increased by 20-30% in the first trimester. Dan Med J. 2014 Dec;61(12):A4959.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
pregnant hypo
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.